V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004305 | 10002722 | 1.71 | 0 | Adjuvant (A) | 2017-10-19 | 2017-11-09 | Fluorouracil + Folinic Acid Weekly | N | N | 10517770 | FLUOROURACIL |
| 10004306 | 10002723 | 1.6 | 62.2 | Curative (C) | 2019-03-05 | 2019-03-16 | CISPLATIN + ETOPOSIDE | N | N | 10517818 | FLUOROURACIL + MITOMYCIN + RT |
| 10004307 | 10002723 | 1.71 | 72.6 | Curative (C) | 2017-04-25 | 2017-05-10 | Chlorambucil | null | N | 10517818 | CVD |
| 10004308 | 10002723 | 1.75 | 74 | Curative (C) | 2015-09-10 | 2015-09-21 | Cisplatin + Radiotherapy | 99 | N | 10517818 | CISPLATIN + RT |
| 10004309 | 10002724 | 1.75 | 112.6 | Palliative (P) | 2016-05-06 | 2016-05-08 | CHOP - 21 days | 02 | N | 10517995 | PACLITAXEL |
| 10004310 | 10002725 | 1.66 | 55 | Adjuvant (A) | 2018-12-08 | 2018-12-08 | BCG Intravesical | 02 | N | 10518098 | CHLORAMBUCIL |
| 10004311 | 10002726 | 1.6 | 75.4 | Adjuvant (A) | 2016-10-08 | 2016-10-22 | FEC + DOCETAXEL | N | N | 10518110 | FEC + DOCETAXEL |
| 10004312 | 10002726 | 1.62 | 96.9 | Curative (C) | 2017-05-23 | 2017-06-01 | Bortezomib +/- Dexamethasone | 2 | N | 10518110 | ABIRATERONE |
| 10004313 | 10002726 | 1.8 | 58.5 | Curative (C) | 2017-01-13 | 2017-01-13 | BCG Intravesical | N | N | 10518110 | CHLORAMBUCIL |
| 10004314 | 10002727 | 1.8 | 81.3 | Neo-adjuvant (N) | 2017-08-22 | 2017-09-18 | Capecitabine 35days + RT | 02 | Y | 10518276 | CAPECITABINE + RT |
| 10004315 | 10002728 | null | 76.4 | Disease modification (D) | 2016-09-27 | 2016-10-06 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10518314 | TEMOZOLOMIDE + RT |
| 10004316 | 10002729 | 1.8 | 71 | Palliative (P) | 2015-09-10 | 2015-10-01 | Azacitidine | N | N | 10518437 | TEMOZOLOMIDE + RT |
| 10004317 | 10002729 | 1.64 | 111 | Adjuvant (A) | null | 2016-09-15 | BCG Intravesical | N | N | 10518437 | CVD |
| 10004318 | 10002730 | 1.81 | 0 | Adjuvant (A) | 2017-11-09 | 2017-11-09 | Fluorouracil + Folinic Acid Weekly | N | N | 10518616 | FLUOROURACIL |
| 10004319 | 10006621 | 1.75 | 0 | Curative (C) | 2012-02-14 | 2019-03-12 | Capecitabine 35days + RT | 2 | N | 10518640 | CAPECITABINE + RT |
| 10004320 | 10002731 | 1.81 | 76.2 | Adjuvant (A) | 2017-02-23 | 2017-03-08 | FLUOROURACIL | 02 | N | 10518694 | FLUOROURACIL |
| 10004321 | 10002732 | null | 85.7 | Curative (C) | 2016-04-24 | 2016-05-08 | Azacitidine | N | N | 10518709 | AZACITIDINE |
| 10004322 | 10002733 | 1.63 | 124 | Palliative (P) | 2017-05-07 | 2017-05-18 | Cisplatin + Etoposide po&iv 3 day | N | N | 10518885 | ABIRATERONE |
| 10004323 | 10002734 | 1.62 | 60.8 | Palliative (P) | 2016-06-26 | 2016-07-08 | CTD | N | N | 10519012 | BCG |
| 10004324 | 10002735 | 1.56 | 0 | Adjuvant (A) | 2017-10-11 | 2017-11-01 | BCG Intravesical | 02 | N | 10519073 | AZACITIDINE |
| 10004325 | 10002736 | 0 | 65 | Palliative (P) | 2018-03-23 | 2018-03-23 | Chlorambucil | N | Y | 10519085 | TEMOZOLOMIDE + RT |
| 10004326 | 10002736 | 1.58 | 0 | Palliative (P) | 2015-01-21 | 2015-01-22 | BCG Intravesical | 2 | N | 10519085 | FLUOROURACIL + MITOMYCIN + RT |
| 10004327 | 10002737 | 1.78 | 77.5 | null | 2016-12-31 | 2017-02-17 | Cisplatin | N | N | 10519147 | AZACITIDINE |
| 10004328 | 10002737 | 1.73 | 90.6 | Palliative (P) | 2017-05-25 | 2017-05-25 | Abiraterone | null | N | 10519147 | EC |
| 10004329 | 10002738 | null | null | Curative (C) | 2018-03-08 | 2018-03-11 | ABVD | N | N | 10519170 | PACLITAXEL |
| 10004330 | 10006624 | 1.72 | 63 | Adjuvant (A) | 2017-10-24 | 2017-11-08 | Bortezomib | N | N | 10519214 | BCG |
| 10004331 | 10006624 | 1.71 | 73.8 | Palliative (P) | 2018-09-20 | 2018-09-20 | Fluorouracil + Folinic Acid Weekly | N | N | 10519214 | FLUOROURACIL |
| 10004332 | 10002739 | 1.59 | 95.9 | null | 2016-10-24 | 2016-11-12 | Bortezomib +/- Dexamethasone | 2 | Y | 10519320 | AZACITIDINE |
| 10004333 | 10002740 | 1.62 | 66.2 | Curative (C) | 2014-07-19 | 2014-07-19 | Temozolomide + RT | 02 | Y | 10519327 | ABIRATERONE |
| 10004334 | 10002741 | 1.8 | 0 | Neo-adjuvant (N) | 2017-07-18 | 2017-07-25 | FEC + DOCETAXEL | N | N | 10519337 | FEC + DOCETAXEL |
| 10004335 | 10002742 | null | null | Curative (C) | null | 2017-01-31 | Paclitaxel (2 or 3 weekly) | null | null | 10519345 | BORTEZOMIB |
| 10004336 | 10002743 | 0 | 85 | Curative (C) | 2015-04-01 | 2015-04-14 | CAPECITABINE + GEMCITABINE | N | null | 10519362 | PACLITAXEL |
| 10004337 | 10002743 | 1.66 | null | Palliative (P) | 2015-04-23 | 2015-05-05 | Capecitabine + Cisplatin | 02 | N | 10519362 | BCG |
| 10004338 | 10002744 | 1.7 | 66.75 | Palliative (P) | 2016-08-28 | 2016-09-17 | ABVD | 02 | Y | 10519461 | BCG |
| 10004339 | 10002745 | 1.8 | 118 | Curative (C) | 2014-06-04 | 2014-06-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10519485 | EC |
| 10004340 | 10006626 | null | 55 | Disease modification (D) | 2019-01-28 | 2019-02-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | Y | N | 10519624 | BORTEZOMIB |
| 10004341 | 10006626 | 1.69 | 61.8 | Curative (C) | 2015-10-16 | 2015-10-23 | Gemcitabine + Capecitabine | 02 | N | 10519624 | CISPLATIN |
| 10004342 | 10002746 | 1.8 | 71.8 | Adjuvant (A) | 2013-07-18 | 2013-07-20 | Capecitabine + Cisplatin | N | N | 10519786 | PACLITAXEL |
| 10004343 | 10002747 | 1.65 | 82.8 | Adjuvant (A) | 2015-04-22 | 2015-04-22 | BCG Intravesical | N | N | 10519801 | FLUOROURACIL + MITOMYCIN + RT |
| 10004344 | 10002748 | 1.78 | null | Disease modification (D) | 2016-01-25 | 2016-02-28 | EC | null | Y | 10519825 | CISPLATIN + ETOPOSIDE |
| 10004345 | 10002749 | 1.63 | 82 | null | 2014-10-30 | 2014-11-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10519843 | CISPLATIN |
| 10004346 | 10002749 | 1.57 | 71 | Disease modification (D) | 2018-01-23 | 2018-01-30 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | Y | 10519843 | FLUOROURACIL + MITOMYCIN + RT |
| 10004347 | 10006628 | 1.8 | 85.6 | Adjuvant (A) | 2015-08-23 | 2015-08-25 | Azacitidine | 2 | N | 10519919 | PACLITAXEL |
| 10004348 | 10002750 | 1.63 | 95.6 | Neo-adjuvant (N) | 2018-07-14 | 2018-07-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10519977 | CTD |
| 10004349 | 10002751 | 1.81 | 84 | Curative (C) | 2014-08-21 | 2014-09-15 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 10519994 | TEMOZOLOMIDE + RT |
| 10004350 | 10002752 | 0 | 57.9 | Palliative (P) | 2017-04-30 | 2017-04-30 | BCG Intravesical | 2 | Y | 10520070 | EC |
| 10004351 | 10006629 | 1.77 | 74.7 | Palliative (P) | 2018-01-21 | 2018-02-24 | CAPECITABINE + GEMCITABINE | null | Y | 10520115 | CHLORAMBUCIL |
| 10004352 | 10006629 | 1.72 | 59.8 | Disease modification (D) | 2015-08-22 | 2015-09-03 | Abiraterone | 2 | N | 10520115 | CTD |
| 10004353 | 10006629 | 1.76 | 48.2 | Disease modification (D) | 2014-01-31 | 2014-02-07 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10520115 | ABIRATERONE |
| 10004354 | 10006629 | 1.71 | 85 | null | 2016-11-26 | 2016-12-10 | Temozolomide + RT | 02 | N | 10520115 | CHOP |